|
Market Closed -
Nasdaq
04:00:00 31/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 0.3351 USD | -9.68% |
|
-35.08% | -94.52% |
Evolution of the Average Target: Actuate Therapeutics, Inc.
Evolution of the Target Price: Actuate Therapeutics, Inc.
Changes in Analyst Recommendations: Actuate Therapeutics, Inc.
fcb903e445.KbYSETFaky5um0YxxOQGkcI79O3cifmH3LU2Mb5V2_8.ToNQJHgZxlQ6zzdbqalz_pICsK6w_J7Im896QvUksrFKxGpeZwDbeDfrMQ~dfc6b1caf8a4b65019cd09c139b0b12e
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | +3,049.15% | |||||
| +41.6% | |||||
| +24.9% | |||||
| +8.71% | |||||
| +12.62% | |||||
| +17.47% | |||||
| +36.04% | |||||
| +1% | |||||
| +42.98% | |||||
| +33.85% | |||||
| Average | +326.83% | |||||
| Weighted average by Cap. | +24.47% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.3710USD
Average target price
11.68USD
Spread / Average Target
+3,049.15%
High Price Target
15.05USD
Spread / Highest target
+3,956.60%
Low Price Target
8.000USD
Spread / Lowest Target
+2,056.33%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- ACTU Stock
- Consensus Actuate Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
